Skip to main content
. 2011 Aug 11;61(1):41–48. doi: 10.1007/s00262-011-1089-0

Fig. 3.

Fig. 3

Position emission tomography (PET) scans of thorax metastasis in a 47-year-old male patient prior to treatment (a) and immediately before the fourth maintenance dose of ipilimumab (b); Fig. 3c–e show subcutaneous soft tissue lesions of the lower legs prior to treatment (c), immediately before the fourth maintenance dose of ipilimumab (d), and immediately before the eighth maintenance dose of ipilimumab at Week 108 (e)